Whitehawk Therapeutics, Inc.
WHWK
$1.57
$0.031.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.15% | 2.72% | -6.27% | -11.23% | -8.68% |
| Total Depreciation and Amortization | 14.20% | 11.11% | 34.53% | 47.15% | 6.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.08% | 29.10% | 31.37% | -11.18% | -25.51% |
| Change in Net Operating Assets | -77.73% | 44.97% | 177.62% | 84.97% | -87.03% |
| Cash from Operations | 0.19% | 11.72% | 12.45% | -12.56% | -20.19% |
| Capital Expenditure | 58.36% | 29.38% | -42.72% | -86.70% | -794.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -69.19% | 1,233.63% | 141.73% | 170.39% | 165.82% |
| Cash from Investing | -69.71% | 425.96% | 135.45% | 166.45% | 162.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -69.96% | -70.33% | -99.71% | -99.35% | -99.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 90.00% | 90.93% | 73.61% | 74.20% | 75.72% |
| Cash from Financing | -60.12% | 12.95% | -99.89% | -99.57% | -99.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -243.36% | 42.03% | 46.57% | 120.61% | 121.72% |